Inloggen

Login
 
Wachtwoord vergeten?

Deinove gaat Fermentalg achterna

Volgen
 
Klik hier om dit forumtopic te volgen en automatisch op de hoogte gehouden te worden bij nieuwe berichten.
56 Posts, Pagina: « 1 2 3 | Laatste
Aantal posts per pagina:  20 50 100 | Omlaag ↓
poil-1
0
In de min.
Dat kan gebeuren, maar ik blijf zitten.
Eind van de dag verwacht ik nog de plus.
Groet, poil
poil-1
0
Pfff.
Drukt even door naar beneden.
Ga er van uit dat de 1 euro niet wordt gebroken.
Afwachten.
Prettig weekend, poil
Leeser1959
0
quote:

poil-1 schreef op 10 januari 2020 15:07:


Pfff.
Drukt even door naar beneden.
Ga er van uit dat de 1 euro niet wordt gebroken.
Afwachten.
Prettig weekend, poil


Doe je nog wat in Deinove ?

Met vriendelijke groet "Leeser1959"
poil-1
0
Leeser1959
0
quote:

poil-1 schreef op 23 januari 2020 19:09:


Jazeker. Iets afgebouwd, dat wel. Maar nog zeker genoeg :).
Groet, poil


Volgens mij positieve ontwikkelingen bij Deinove.

Heb op lagere koersen nog wat bijkooporders ingelegd.

Leeser1959
0
@poil;

wat vind jij van Deinove rond de 0,90 ?

Continu aanbod vanuit de convertible ?

Gr. Leeser
Leeser1959
0

Sharon Laboratories capitalizes on Deinove to sustain its development activities









06.02.2020



•The signed Memorandum of Understanding (MoU) covers the development and marketing of an exclusive range of bio-based ingredients for personal care from DEINOVE’s platform.
•This decisive and unprecedented agreement, to be finalized by the end of March 2020, will have an initial term of 3 years and provides for partial financing of activities and royalties on sales.
•Even before the conclusion of the contractual agreement, Sharon Laboratories demonstrates its commitment with the immediate payment of $200k, being only a part of the substantial upfront payment to be paid after the signing of the final agreement.

DEINOVE (Euronext Growth Paris: ALDEI), a French biotech company that uses a disruptive approach to develop innovative antibiotics and bio-based active ingredients for cosmetics, announced having signed a Memorandum of Understanding (MoU) with the Israeli group Sharon Laboratories, a specialist in preservative solutions for personal care. It aims at entering into an exclusive partnership for the development and marketing of a range of new bio-based solutions, including bioactives, arising from DEINOVE’s platform.

Expanding the potential of DEINOVE’s platform towards advanced bio-based applications

Sharon Laboratories is a world leader in preservative solutions for personal care. Driven by the growing consumer and brand demand for naturally and sustainably sourced ingredients, Sharon Laboratories wishes to entrust DEINOVE with joint development of a new range of bio-based and differentiated solutions.

This collaborative R&D program will benefit from DEINOVE's accumulated expertise in leveraging the properties of its collection of rare microorganisms. It will expand the potential of DEINOVE's biotechnology platform to a substantial and promising market, building on Sharon Laboratories 40 years of experience in the personal care preservation field. The global cosmetic market is seeking natural solutions to replace existing synthetic ingredients. As the natural cosmetics segment continues to grow, the demand for such ingredients will grow with it.

The draft agreement grants an exclusivity in various ingredient and functions to Sharon Laboratories, keeping DEINOVE's free to develop additional collaborations.

A path-breaking partnership

DEINOVE and Sharon Laboratories have signed an MoU for an agreement to be finalized by the end of the first quarter of 2020. This decisive agreement has an initial term of 3 years and provides for the regular payment of significant milestones, amounting to several millions of dollars, as well as royalties on sales once commercialized. Sharon Laboratories demonstrates its commitment with the immediate $200k payment.

"This upcoming decisive and unprecedented agreement with Sharon Laboratories underlines the quality and versatility of our technological platform. Expanding into the demanding and promising new fields and functions is a great opportunity for DEINOVE. Doing so in the framework of an exclusive agreement with one of the main industry leaders, who shows his commitment already today, would ensure our success", says Charles Woler, CEO of DEINOVE.

"We are excited to enter into this new field which we believe is the future of the cosmetic industry. Sharon Laboratories created a strong foundation for expedited growth, and we find DEINOVE to be the right partner to join us in this journey. We believe DEINOVE's technology, know-how and people align well with Sharon's strong capabilities and growth strategy", says Ari Melamud, CEO of Sharon Laboratories.
Leeser1959
0

DEINOVE expands its range of cosmetic active ingredients









19.02.2020



•Its second innovative carotenoid has the particularity of absorbing blue light, which is responsible for premature skin ageing, the appearance of skin spots, a loss of radiance and vitality.
•Efficacy tests carried out on human skin explants confirmed its protective properties and also revealed that it plays an active role on key parameters contributing to skin lightening.
•The new ingredient will be officially launched at in-Cosmetics Global (31 March-2 April, Barcelona).

DEINOVE (Euronext Growth Paris: ALDEI), a French biotech company that uses a disruptive approach to develop innovative antibiotics and bio-based active ingredients for cosmetics, confirms being in the process of finalizing the development of its 2nd proprietary cosmetic active ingredient, for its official launch at the upcoming in-Cosmetics Global trade show.

DEINOVE has developed a new cosmetic active ingredient, produced by fermentation and based on a totally original carotenoid, designed to restore radiance and vitality to the skin.

Its ability to absorb blue light* and its outstanding antioxidant properties had been demonstrated in vitro.

Ex vivo studies have since been carried out, confirming these properties and revealing additional features, particularly in terms of complexion homogeneity and brightness, which are particularly sought by the cosmetics industry.

The active is currently being clinically tested and data will be available for the official launch.

"We are actively preparing the launch of this 2nd proprietary active ingredient which will be officially presented at in-Cosmetics Global, the world's largest trade show dedicated to cosmetic ingredients, taking place in Barcelona from March 31 to April 2. After a promising preview at in-Cosmetics Asia last fall, we will be able to present robust data demonstrating the efficacy and original mechanism of action of this active ingredient, " says Coralie MARTIN, Marketing Manager at DEINOVE.





* Blue light is emitted not only by the sun, but also by screens (TV, computers, smartphones, tablets), electronics and lighting. This light radiation is known for its harmful effects on the health and beauty of the skin. Digital pollution is an emerging issue in cosmetics, given the increasing exposure to blue light produced by screens or LEDs.



? PR in English
poil-1
0
poil-1
0
Deinove 0,995 0,059 6,30 % 12:16:17

Voor het laatst onder de euro.
Het is nu tijd (zeker na het goede nieuws van deze maand) om weer een forse stap hoger te zetten.
Succes, poil
poil-1
0
Deinove - Phase II study with DNV3837 for C. diff starts
Deinove reported that the first patient has been enrolled in its Phase II study with a novel quinolonyl-oxazolidinone class antibiotic DNV3837 for moderate to severe C. diff infections. The results are expected by the end of 2020, which will be a substantial catalyst for the share price. The company also reported multiple developments in its bioactives portfolio, including a new substantial collaboration with a partner that has experience in commercialising preservative solutions for personal care products. We have slightly increased our valuation to €78m or €4.6/share.
poil-1
0
Ik verwacht dat we vandaag nog wel richting de 1,15 - 1,20 kunnen gaan.
Ik verwacht de aankomende periode een fors herstel. Koersdoel 4,60 !
Succes, poil
poil-1
0
En nu voor het laatst pennystock
Deinove 1,00 0,064 6,84 % 12:58:53

The only way is up!

Succes, poil
poil-1
0
Alle signalen staan op groen.
Een spelbreker ;) zet de koers nog even op 98.
Straks gaat het pas echt los.
Ik neem nu al een biertje op de 25% plus van vandaag!
Succes, poil
Leeser1959
0
quote:

poil-1 schreef op 21 februari 2020 13:14:


Alle signalen staan op groen.
Een spelbreker ;) zet de koers nog even op 98.
Straks gaat het pas echt los.
Ik neem nu al een biertje op de 25% plus van vandaag!
Succes, poil


Rustig aan poil-1, e komen doorlopend nieuwe aandelen bij vanuit de convertible !!

Ik ben overigens zeker positief.
56 Posts, Pagina: « 1 2 3 | Laatste
Aantal posts per pagina:  20 50 100 | Omhoog ↑

Plaats een reactie

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord

Direct naar Forum

Indices

AEX 483,44 +1,57%
EUR/USD 1,1010 -0,19%
Germany30^ 9.825,20 -1,11%
Gold spot 1.580,88 +0,46%
LDN100-24h 5.643,29 0,00%
NY-Nasdaq Composite 7.700,10 -0,95%

Stijgers

WDP
+11,84%
Aperam
+8,62%
Arcelo...
+8,60%
Boskalis
+8,08%
Brunel
+7,89%

Dalers

ICT Group
-8,64%
ING
-4,23%
B&S Gr...
-3,46%
Akzo N...
-2,90%
VIVORY...
-2,19%
 
Quotedata: Amsterdam realtime by Euronext, other realtime by Cboe Europe Ltd.   US stocks: by NYSE & Cboe BZX Exchange, 15min delayed
#/^ Index indications calculated real time, zie disclaimer, streaming powered by VWD Group Crypto data by Crypto Compare